omnipaque 350 mg i/ml raztopina za injiciranje
ge healthcare as - jod - raztopina za injiciranje - jod 350 mg / 1 ml - joheksol
omnipaque 350 mg i/ml raztopina za injiciranje
ge healthcare as - jod - raztopina za injiciranje - jod 350 mg / 1 mljoheksol - joheksol
iomeron 400 mg/ml raztopina za injiciranje
bracco imaging s.p.a. - jod - raztopina za injiciranje - jod 400 mg / 1 mljomeprol - jomeprol
omnipaque 350 mg i/ml raztopina za injiciranje
ge healthcare as - jod - raztopina za injiciranje - jod 350 mg / 1 ml - joheksol
omnipaque 300 mg i/ml raztopina za injiciranje
ge healthcare as - jod - raztopina za injiciranje - jod 300 mg / 1 ml joheksol - joheksol
omnipaque 350 mg i/ml raztopina za injiciranje
ge healthcare as - jod - raztopina za injiciranje - jod 350 mg / 1 ml - joheksol
omnipaque 350 mg i/ml raztopina za injiciranje
ge healthcare as - jod - raztopina za injiciranje - jod 350 mg / 1 ml joheksol - joheksol
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - zdravila za obstruktivne pljučne bolezni, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
fosicard hct 20 mg/12,5 mg tablete
actavis group hf - fozinopril; hidroklorotiazid - tableta - fozinopril 19,2 mg / 1 tableta hidroklorotiazid12,5 mg / 1 tableta; hidroklorotiazid 12,5 mg / 1 tableta - fozinopril in diuretiki
fosicard hct 20 mg/12,5 mg tablete
actavis group hf - fozinopril; hidroklorotiazid - tableta - fozinopril 19,2 mg / 1 tableta hidroklorotiazid12,5 mg / 1 tableta; hidroklorotiazid 12,5 mg / 1 tableta - fosinopril in diuretiki